NextCure Insider Trades
NASDAQ: NXTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 19 · $1.85M
- Sales
- 1 · $184.80K
- Shares bought / sold
- 374.63K / 30.00K
- Net activity
- Net buying $1.7 million
NextCure insider activity
Over the last 12 months, NextCure insiders reported 20 transactions on SEC Form 4: 19 open-market purchases and 1 sale. Insiders bought $1.9 million and sold $184,800 worth of stock, for net insider buying of $1.7 million. The largest seller was Simcere Zaiming, Inc. & Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. & Simcere Zaiming Pharmaceutical Co., Ltd. & Simcere Pharmaceutical Group Ltd & Ren Jinsheng & Tang Renhong, with $184,800 in reported sales.
The most recent filing shows ADAR1 Capital Management, LLC & Schneeberger Daniel (10% Owner) buying 12,333 shares at $5.10 on Nov 11, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NXTC's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
NXTC insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 11, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 12,333 | $62.90K | Form 4 |
| Nov 6, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 3,662 | $18.68K | Form 4 |
| Nov 5, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 1,024 | $5.22K | Form 4 |
| Oct 27, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 3,553 | $18.10K | Form 4 |
| Oct 26, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 1,672 | $8.42K | Form 4 |
| Oct 23, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 5,626 | $27.17K | Form 4 |
| Aug 10, 2026 | Simcere Zaiming, Inc. & Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. & Simcere Zaiming Pharmaceutical Co., Ltd. & Simcere Pharmaceutical Group Ltd & Ren Jinsheng & Tang RenhongFormer 10% Owner | Sale | 30,000 | $184.80K | Form 4 |
| Jul 31, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 8,003 | $38.41K | Form 4 |
| Jul 31, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 25,000 | $124.54K | Form 4 |
| Jul 31, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 3,300 | $16.42K | Form 4 |
| Jul 30, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 77,850 | $385.79K | Form 4 |
| Jul 30, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 100,000 | $490.00K | Form 4 |
| Jul 30, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 25,000 | $120.34K | Form 4 |
| Jul 30, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 20,000 | $100.00K | Form 4 |
| Jul 30, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 20,000 | $100.00K | Form 4 |
| Jul 30, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 50,000 | $248.62K | Form 4 |
| Jul 29, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 1,600 | $8.00K | Form 4 |
| Jul 29, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 1,810 | $9.05K | Form 4 |
| Jul 28, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 6,400 | $31.68K | Form 4 |
| Jul 27, 2026 | ADAR1 Capital Management, LLC & Schneeberger Daniel10% Owner | Buy | 7,798 | $38.99K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4